nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical Universitynefr-106Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESСОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ ОБ ЭТИОЛОГИИ И ПАТОГЕНЕЗЕ ИДИОПАТИЧЕСКОЙ ГИПЕРКАЛЬЦИУРИИMODERN VIEWS ON IDIOPATHIC HYPERCALCIURIA AETIOLOGY AND PATHOGENESISМихееваН. М.MikheevaN. M.micheeva.1974@mail.ruЗверевЯ. Ф.ZverevYa. F.noemail@neicon.ruВыходцеваГ. И.VykhodcevaG. I.noemail@neicon.ruАлтайский государственный медицинский университетРоссияAltai State Medical UniversityRussian Federation2015010720151942940Copyright © Михеева Н.М., Зверев Я.Ф., Выходцева Г.И., 20152015Михеева Н.М., Зверев Я.Ф., Выходцева Г.И.Mikheeva N.M., Zverev Y.F., Vykhodceva G.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/106

В обзоре обобщены данные об этиологии и патогенезе идиопатической гиперкальциурии. Рассматриваются основные виды гиперкальциурии. Обсуждаются различные причины и механизмы развития данного метаболического нарушения.

This review summarizes data on the idiopathic hypercalciuria aetiology and pathogenesis. The basic types of hypercalciuria are considered. The different causes and mechanisms of this metabolic disorder are discussed.

идиопатическая гиперкальциурияэтиологияпатогенезidiopathic hypercalciuriaaetiologypathogenesisReferencesLiebman SE, Taylor JG, Bushinsky DA. Idiopathic hypercalciuria. Curr Rheumatol Rep 2006; 8 (1): 70-75Liebman SE, Taylor JG, Bushinsky DA. Idiopathic hypercalciuria. Curr Rheumatol Rep 2006; 8 (1): 70-75Spivacow FR, Negri AL, del Valle EE et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23: 1129-1133Spivacow FR, Negri AL, del Valle EE et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23: 1129-1133Vezzoli G, Soldati L, Gambaro G. Hypercalciuria revisited: one or many conditions? Pediatr Nephrol 2008; 23: 503-506Vezzoli G, Soldati L, Gambaro G. Hypercalciuria revisited: one or many conditions? Pediatr Nephrol 2008; 23: 503-506Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 2008; 28 (2): 120-132Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 2008; 28 (2): 120-132Bak M, Ural R, Agin H et al. The metabolic etiology of urolithiasis in Turkish children. Urol Nephrol 2009; 41: 453-460Bak M, Ural R, Agin H et al. The metabolic etiology of urolithiasis in Turkish children. Urol Nephrol 2009; 41: 453-460Lau KK. Clinical manifestations of pediatric idiopathic hypercalciuria. Front Biosci(Elite Ed) 2009; 1: 52-59Lau KK. Clinical manifestations of pediatric idiopathic hypercalciuria. Front Biosci(Elite Ed) 2009; 1: 52-59Srivastava T, Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr 2009; 21 (2): 214-219Srivastava T, Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr 2009; 21 (2): 214-219Naseri M, Alamdaran SA. Metabolic factors associated with urinary calculi in children. Iran J Kidney Dis 2010; 4 (1): 32-38Naseri M, Alamdaran SA. Metabolic factors associated with urinary calculi in children. Iran J Kidney Dis 2010; 4 (1): 32-38Wróblewski T, Wystrychowski A. Hypercalciuria. Przegl Lek 2011; 68 (2): 107-113Wróblewski T, Wystrychowski A. Hypercalciuria. Przegl Lek 2011; 68 (2): 107-113Copelovitch L. Urolithiasis in children. Pediatr Clin North Am 2012; 59 (4): 881-896Copelovitch L. Urolithiasis in children. Pediatr Clin North Am 2012; 59 (4): 881-896Albright F, Henneman P, Benedict PH, Forbes AP. Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med 1953; 46 (12): 1077-1081Albright F, Henneman P, Benedict PH, Forbes AP. Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med 1953; 46 (12): 1077-1081Butani L, Kalia A. Idiopathic hypercalciuria in children - how valid are the existing diagnostic criteria? Pediatr Nephrol 2004; 19 (6): 577-582Butani L, Kalia A. Idiopathic hypercalciuria in children - how valid are the existing diagnostic criteria? Pediatr Nephrol 2004; 19 (6): 577-582Vezzoli G, Soldati L, Gambaro G. Update on primary hypercalciuria from a genetic perspective. J Urol 2008; 179: 1676-1682Vezzoli G, Soldati L, Gambaro G. Update on primary hypercalciuria from a genetic perspective. J Urol 2008; 179: 1676-1682Emamghorashi F, Davami MH, Rohi R. Hypercalciuria in Jahrom’s school-age children: what is normal calcium-creatinine ratio? Iran J Kidney Dis 2010; 4 (2): 112-115Emamghorashi F, Davami MH, Rohi R. Hypercalciuria in Jahrom’s school-age children: what is normal calcium-creatinine ratio? Iran J Kidney Dis 2010; 4 (2): 112-115Kaneko K, Tsuchiya K, Kawamura R et al. Low prevalence of hypercalciuria in Japanese children. Nephron 2002; 91: 439-443Kaneko K, Tsuchiya K, Kawamura R et al. Low prevalence of hypercalciuria in Japanese children. Nephron 2002; 91: 439-443Pak CY, Kaplan R, Bone H et al. A simple test to the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 1975; 292 (10): 497-500Pak CY, Kaplan R, Bone H et al. A simple test to the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 1975; 292 (10): 497-500Pak CY, Sakhaee K, Pearle MS. Detection of absorptive hypercalciuria type I without the oral calcium load test. J Urol 2011; 185(3): 915-919Pak CY, Sakhaee K, Pearle MS. Detection of absorptive hypercalciuria type I without the oral calcium load test. J Urol 2011; 185(3): 915-919Bataille P, Fardellone P, Ghazali A et al. Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol 1998; 10 (4): 373-388Bataille P, Fardellone P, Ghazali A et al. Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol 1998; 10 (4): 373-388Pak CX, Resnick MI. Medical therapy and new approaches to management of urolithiasis. Urol Clin North Am 2000; 27: 243253Pak CX, Resnick MI. Medical therapy and new approaches to management of urolithiasis. Urol Clin North Am 2000; 27: 243253Stapleton FB, Jones DP, Miller LA. Evaluation of bone metabolism in children with hypercalciuria. Semin Nephrol 1989; 9 (1): 75-78Stapleton FB, Jones DP, Miller LA. Evaluation of bone metabolism in children with hypercalciuria. Semin Nephrol 1989; 9 (1): 75-78Nicolaidou P, Themeli S, Karpathios T et al. Family pattern of idiopathic hypercalciuria and its subtypes. J Urol 1996; 155: 1042-1044Nicolaidou P, Themeli S, Karpathios T et al. Family pattern of idiopathic hypercalciuria and its subtypes. J Urol 1996; 155: 1042-1044Maierhofer WJ, Lemann JJr, Gray RW, Cheung HS. Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men. Kidney Int 1984; 26 (5): 752-759Maierhofer WJ, Lemann JJr, Gray RW, Cheung HS. Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men. Kidney Int 1984; 26 (5): 752-759Scwaderer A, Srivastava T. Complications of hypercalci-uria. Front Biosci (Elite Ed) 2009; 1: 306-315Scwaderer A, Srivastava T. Complications of hypercalci-uria. Front Biosci (Elite Ed) 2009; 1: 306-315Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol 1997; 8 (10): 1568-1573Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol 1997; 8 (10): 1568-1573Polito C, La Manna A, Cioce F et al. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol 2000; 15 (3-4): 211-214Polito C, La Manna A, Cioce F et al. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol 2000; 15 (3-4): 211-214Bianco SD, Peng JB, Takanaga H et al. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res 2007; 22: 274-285Bianco SD, Peng JB, Takanaga H et al. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res 2007; 22: 274-285Jackman SV, Kibel AS, Ovuworie CA et al. Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. J Endocrinol 1999; 13: 313-316Jackman SV, Kibel AS, Ovuworie CA et al. Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. J Endocrinol 1999; 13: 313-316Zerwekh JE, Reed BX, Heller HJ et al. Normal vitamin D concentration and responsiveness to 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 1998; 24: 307-313Zerwekh JE, Reed BX, Heller HJ et al. Normal vitamin D concentration and responsiveness to 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 1998; 24: 307-313Lerolle N, Coulet F, Lantz B et al. No evidence for point mutations of the calcium-sensing receptor in familial idiopathic hypercalciuria. Nephrol Dial Transplant 2001; 16: 2317-2322Lerolle N, Coulet F, Lantz B et al. No evidence for point mutations of the calcium-sensing receptor in familial idiopathic hypercalciuria. Nephrol Dial Transplant 2001; 16: 2317-2322Petrucci M, Scott P, Ouimet D et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int 2000; 58 (1): 38-42Petrucci M, Scott P, Ouimet D et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int 2000; 58 (1): 38-42Scheinman SJ, Cox JP, Lloyd SE et al. Isolated hypercalciuria with mutation in CLCN5: Relevance to idiopathic hypercalciuria. Kidney Int 2000; 57: 232-239Scheinman SJ, Cox JP, Lloyd SE et al. Isolated hypercalciuria with mutation in CLCN5: Relevance to idiopathic hypercalciuria. Kidney Int 2000; 57: 232-239Scott P, Ouimet D, Proulx Y et al. The 1 alpha-hydroxylase locus is not linked to calcium stone formation or calciuric phenotypes in French-Canadian families. J Am Soc Nephrol 1998; 9 (3): 425-432Scott P, Ouimet D, Proulx Y et al. The 1 alpha-hydroxylase locus is not linked to calcium stone formation or calciuric phenotypes in French-Canadian families. J Am Soc Nephrol 1998; 9 (3): 425-432Lapointe J-Y, Tessier J, Paquette Y et al. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int 2006; 69: 2261-2267Lapointe J-Y, Tessier J, Paquette Y et al. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int 2006; 69: 2261-2267Reed BX, Gitomer WL, Heller HJ et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 2002; 87 (4): 1476-1485Reed BX, Gitomer WL, Heller HJ et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 2002; 87 (4): 1476-1485Renkema KY, Lee K, Topala CN et al. TRPV5 gene polymorphisms in renal hypercalciuria. Nephrol Dial Transplant 2009; 24: 1919-1924Renkema KY, Lee K, Topala CN et al. TRPV5 gene polymorphisms in renal hypercalciuria. Nephrol Dial Transplant 2009; 24: 1919-1924Moe OW, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol 2005; 16 (3): 729-745Moe OW, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol 2005; 16 (3): 729-745Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 2003; 14 (4): 1082-1095Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 2003; 14 (4): 1082-1095Lemann JJr. Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. Raven Press, New York, 1992; 685-706Lemann JJr. Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. Raven Press, New York, 1992; 685-706Brannan PG, Morawaki S, Pak CYC, Fordtran JS. Selective jejuna hyperabsorption of calcium in absorptive hypercalciuria. Am J Med 1979; 68: 425-428Brannan PG, Morawaki S, Pak CYC, Fordtran JS. Selective jejuna hyperabsorption of calcium in absorptive hypercalciuria. Am J Med 1979; 68: 425-428Lemann JJr. Idiopathic hypercalciuria. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. Lippincott, 2002;673-697Lemann JJr. Idiopathic hypercalciuria. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. Lippincott, 2002;673-697Coe FL, Parks JH, Evan AP, Worcester E. Pathogenesis and treatment of nephrolithiasis. In: Alpern R, Hebert S, eds. Seldin and Giebisch' The Kidney. Elsevier, Inc., 2007; 1945-1977Coe FL, Parks JH, Evan AP, Worcester E. Pathogenesis and treatment of nephrolithiasis. In: Alpern R, Hebert S, eds. Seldin and Giebisch' The Kidney. Elsevier, Inc., 2007; 1945-1977Hoenderop JGJ, Nilius B, Bindels RJM. Calcium absorption across epithelia. Physiol Rev 2005; 85: 373-422Hoenderop JGJ, Nilius B, Bindels RJM. Calcium absorption across epithelia. Physiol Rev 2005; 85: 373-422Worcester EM, Gillen DL, Evan AP et al. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol 2007; 292: 66-75Worcester EM, Gillen DL, Evan AP et al. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol 2007; 292: 66-75Tsuruoka S, Bushinsky DA, Schwartz GJ. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 1997; 51: 1540-1547Tsuruoka S, Bushinsky DA, Schwartz GJ. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 1997; 51: 1540-1547Sutton RAL, Walker VR. Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. N Engl J Med 1980; 13: 709-713Sutton RAL, Walker VR. Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. N Engl J Med 1980; 13: 709-713Prie D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272-276Prie D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272-276Tenenhouse HS, Gauthier C, Chau H, St-Arnaud R. 1 alpha-Hydroxylase gene ablation and Pi supplementation inhibit renal calcification in mice homozygous for the disrupted Npt2a gene. Am J Physiol Renal Physiol 2004; 286: F675-F681Tenenhouse HS, Gauthier C, Chau H, St-Arnaud R. 1 alpha-Hydroxylase gene ablation and Pi supplementation inhibit renal calcification in mice homozygous for the disrupted Npt2a gene. Am J Physiol Renal Physiol 2004; 286: F675-F681Maierhofer WJ, Gray RW, Adams ND. Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D concentrations in healthy men. Kidney Int 1983; 24 (4): 555-560Maierhofer WJ, Gray RW, Adams ND. Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D concentrations in healthy men. Kidney Int 1983; 24 (4): 555-560Bushinsky DA. Bench to bedside: Lessions from the genetic hypercalciuric stone forming rat. Am J Kidney Dis 2000; 36:61-64Bushinsky DA. Bench to bedside: Lessions from the genetic hypercalciuric stone forming rat. Am J Kidney Dis 2000; 36:61-64Favus MJ, Karnauskas AJ, Park JH et al. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 2004; 89: 4937-4943Favus MJ, Karnauskas AJ, Park JH et al. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 2004; 89: 4937-4943Sandgren M, DeLuca HF. Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo. Proc Natl Acad Sci U S A 1990; 87: 4312-4314Sandgren M, DeLuca HF. Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo. Proc Natl Acad Sci U S A 1990; 87: 4312-4314Yao J, Kathpalia P, Bushinsky DA, Favus MJ. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-di-hydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 1998; 101: 2223-2232Yao J, Kathpalia P, Bushinsky DA, Favus MJ. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-di-hydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 1998; 101: 2223-2232Alhava EM, Juuti M, Karjalainen P. Bone mineral density in patients with urolithiasis. Scand J Urol Nephrol 1976; 10: 154-156Alhava EM, Juuti M, Karjalainen P. Bone mineral density in patients with urolithiasis. Scand J Urol Nephrol 1976; 10: 154-156Fuss M, Pepersack T, Van Geel J et al. Involvement of low calcium diet in the reduced mineral content in idiopathic renal stone formers. Calcif Tissue Int 1990; 46: 9-13Fuss M, Pepersack T, Van Geel J et al. Involvement of low calcium diet in the reduced mineral content in idiopathic renal stone formers. Calcif Tissue Int 1990; 46: 9-13Casez JP, Hug C, Hess B et al. The myth of low bone mass in idiopathic calcium renal stone formers. Kidney Int 1993; 44: 264Casez JP, Hug C, Hess B et al. The myth of low bone mass in idiopathic calcium renal stone formers. Kidney Int 1993; 44: 264Мальцев СВ, Михайлова ТВ, Кравцова ОА. Генетические и клинические аспекты нефролитиаза и нефрокальциноза у детей с гиперкальциурией. Практическая мед 2014; 9 (185): 118-125Мальцев СВ, Михайлова ТВ, Кравцова ОА. Генетические и клинические аспекты нефролитиаза и нефрокальциноза у детей с гиперкальциурией. Практическая мед 2014; 9 (185): 118-125Arrabal-Polo MA, del Carmen Cano-Garcia M, Canales BK, Arrabal-Martin M. Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management. Curr Opin Urol. 2014; 24(6): 633-638.Arrabal-Polo MA, del Carmen Cano-Garcia M, Canales BK, Arrabal-Martin M. Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management. Curr Opin Urol. 2014; 24(6): 633-638.Zerwekh JE. Bone disease and idiopathic hypercalciuria. Semin Nephrol 2008; 28 (2): 133-142Zerwekh JE. Bone disease and idiopathic hypercalciuria. Semin Nephrol 2008; 28 (2): 133-142Malluche HH, Tschoepe W, Ritz E et al. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980; 50: 654-658Malluche HH, Tschoepe W, Ritz E et al. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980; 50: 654-658Weisinger JR. New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int 1996; 49: 1507-1518Weisinger JR. New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int 1996; 49: 1507-1518Freundlich M, Alon US. Bisphosphonates in children with hypercalciuria and reduced bone mineral density. Pediatr Nephrol 2008; 23: 2215-2220Freundlich M, Alon US. Bisphosphonates in children with hypercalciuria and reduced bone mineral density. Pediatr Nephrol 2008; 23: 2215-2220Heller HJ, Zerwekh JE, Gottschalk FA, Pak CY. Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria. Kidney Int 2007; 71: 808-815Heller HJ, Zerwekh JE, Gottschalk FA, Pak CY. Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria. Kidney Int 2007; 71: 808-815Amanzadeh J, Gitomer W, Zerwekh JE et al. Effect of high protein diet on stone forming propensity and bone loss in rats. Kidney Int 2003; 64: 2142-2149Amanzadeh J, Gitomer W, Zerwekh JE et al. Effect of high protein diet on stone forming propensity and bone loss in rats. Kidney Int 2003; 64: 2142-2149Nijenhuis T, Renkema KY, Hoenderop JGJ et al. Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins. J Am Soc Nephrol 2006; 17: 617-626Nijenhuis T, Renkema KY, Hoenderop JGJ et al. Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins. J Am Soc Nephrol 2006; 17: 617-626Asplin JR, Bauer KA, Kinder J et al. Bone mineral density and urine calcium concentration among subjects with and without hypercalciuria. Kidney Int 2003; 63: 662-669Asplin JR, Bauer KA, Kinder J et al. Bone mineral density and urine calcium concentration among subjects with and without hypercalciuria. Kidney Int 2003; 63: 662-669Lau KK, Butani L. Treatment strategies for pediatric idiopathic hypercalciuria. Front Biosci(Elite Ed) 2009; 1: 299-305Lau KK, Butani L. Treatment strategies for pediatric idiopathic hypercalciuria. Front Biosci(Elite Ed) 2009; 1: 299-305Borghi L, Schianchi T, Meschi T et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346 (11): 77-84Borghi L, Schianchi T, Meschi T et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346 (11): 77-84Зверев ЯФ, Брюханов ВМ, Лампатов ВВ, Жариков АЮ. Современные представления о роли физико-химических факторов в патогенезе кальциевого нефролитиаза. Нефрология 2009; 13 (1): 39-50] 2009; 13 (1): 39-50Зверев ЯФ, Брюханов ВМ, Лампатов ВВ, Жариков АЮ. Современные представления о роли физико-химических факторов в патогенезе кальциевого нефролитиаза. Нефрология 2009; 13 (1): 39-50] 2009; 13 (1): 39-50Caudarella R, Vescini F. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital UrolAndrol 2009; 11 (3): 182-187Caudarella R, Vescini F. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital UrolAndrol 2009; 11 (3): 182-187Dogliotti E, Vezzoli G, Nouvenne A et al. Nutrition in calcium nephrolithiasis. J Transl Med 2013, 11:109. Published online 2013, May 1. Doi: 10.1186/1479-5876-11-109Dogliotti E, Vezzoli G, Nouvenne A et al. Nutrition in calcium nephrolithiasis. J Transl Med 2013, 11:109. Published online 2013, May 1. Doi: 10.1186/1479-5876-11-109Penido MG, Lima EM, Souto MF et al. Hypocitruria: a risk factor for reduced bone mineral density in idiopathic hypercalciuria? Pediatr Nephrol 2006; 21: 74-78Penido MG, Lima EM, Souto MF et al. Hypocitruria: a risk factor for reduced bone mineral density in idiopathic hypercalciuria? Pediatr Nephrol 2006; 21: 74-78Garcia-Nieto V, Ferrandez V, Monge M et al. Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr Nephrol 1997; 11 (5): 578-583Garcia-Nieto V, Ferrandez V, Monge M et al. Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr Nephrol 1997; 11 (5): 578-583Dawson-Hughes B, Harris SS, Palermo NJ et al. Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women. J Clin Endocrinol Metab 2009; 94: 96-102Dawson-Hughes B, Harris SS, Palermo NJ et al. Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women. J Clin Endocrinol Metab 2009; 94: 96-102Penido MGMG, Tavares MD, Linhares MC et al. Longitudinal study of bone mineral density in children with idiopathic hypercalciuria. Pediatr Nephrol 2012; 27: 123-130Penido MGMG, Tavares MD, Linhares MC et al. Longitudinal study of bone mineral density in children with idiopathic hypercalciuria. Pediatr Nephrol 2012; 27: 123-130Gambaro GF, Marchini MA, Nassuato A et al. The hyper-calciuric effect of PGE2 in nephrolithiasic patients is mediated by inhibition of Na-K-2Cl cotransport activity. In: Tiselius HG, Akademitryck AB, eds. Renal stones: Aspects of their formation, removal and prevention, Edsbruk, Sweden, 1995; 95-96Gambaro GF, Marchini MA, Nassuato A et al. The hyper-calciuric effect of PGE2 in nephrolithiasic patients is mediated by inhibition of Na-K-2Cl cotransport activity. In: Tiselius HG, Akademitryck AB, eds. Renal stones: Aspects of their formation, removal and prevention, Edsbruk, Sweden, 1995; 95-96Hasanoglu A, Ercan ZS, Buyan N et al. Parathormone, 1,25-dihydroxyvitamin D and prostaglandin E2 correlation in children with idiopathic hypercalciuria. Prostaglandins Leukot Essent Fatty Acids 1997; 56 (3): 235-237Hasanoglu A, Ercan ZS, Buyan N et al. Parathormone, 1,25-dihydroxyvitamin D and prostaglandin E2 correlation in children with idiopathic hypercalciuria. Prostaglandins Leukot Essent Fatty Acids 1997; 56 (3): 235-237Krieger NS, Frick KK, Strutz KL et al. Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro. J Bone Miner Res 2007; 22: 907-917Krieger NS, Frick KK, Strutz KL et al. Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro. J Bone Miner Res 2007; 22: 907-917Zerwekh JE. Bone disease and hypercalciuria in children. Pediatr Nephrol 2010; 25: 395-401Zerwekh JE. Bone disease and hypercalciuria in children. Pediatr Nephrol 2010; 25: 395-401Жариков АЮ, Зверев ЯФ, Брюханов ВМ, Лампатов ВВ. Механизм формирования кристаллов при оксалатном нефро-литиазе. Нефрология 2009; 13 (4): 37-50Жариков АЮ, Зверев ЯФ, Брюханов ВМ, Лампатов ВВ. Механизм формирования кристаллов при оксалатном нефро-литиазе. Нефрология 2009; 13 (4): 37-50Baggio D, Budakovic A, Nassuato A et al. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 2000; 58 (3): 1278-1284Baggio D, Budakovic A, Nassuato A et al. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 2000; 58 (3): 1278-1284Ortiz-Alvarado O, Miyaoka R, Kriedberg C et al. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers. Urology 2012; 79 (2): 282-286Ortiz-Alvarado O, Miyaoka R, Kriedberg C et al. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers. Urology 2012; 79 (2): 282-286Зверев ЯФ, Брюханов ВМ, Талалаева ОС и др. О роли процессов свободно-радикального окисления в развитии экспериментального нефролитиаза. Нефрология 2008; 12 (1): 58-63Зверев ЯФ, Брюханов ВМ, Талалаева ОС и др. О роли процессов свободно-радикального окисления в развитии экспериментального нефролитиаза. Нефрология 2008; 12 (1): 58-63Мотина НВ, Зверев ЯФ, Лепилов АВ и др. Оксидатив-ное повреждение почек при экспериментальном оксалатном нефролитиазе. Нефрология 2010; 14 (1): 68-72Мотина НВ, Зверев ЯФ, Лепилов АВ и др. Оксидатив-ное повреждение почек при экспериментальном оксалатном нефролитиазе. Нефрология 2010; 14 (1): 68-72Pacifici R, Rothstein M, Rifers L et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting hypercalciuria. J Clin Endocrinol Metab 1990; 71 (1): 138-145Pacifici R, Rothstein M, Rifers L et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting hypercalciuria. J Clin Endocrinol Metab 1990; 71 (1): 138-145Classen N, Potgieter HC, Seppa M. Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: Effects of free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. Bone 1995; 16: 385-392Classen N, Potgieter HC, Seppa M. Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: Effects of free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. Bone 1995; 16: 385-392Freundlich M, Alonzo E, Bellorini-Font E, Weisinger JR. Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 2002; 17 (8): 1396-1401Freundlich M, Alonzo E, Bellorini-Font E, Weisinger JR. Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 2002; 17 (8): 1396-1401Santos Jr ACS, Lima EM, Penido MGMG et al. Plasma and urinary levels of cytokines in patients eith idiopathic hypercalciuria. Pediatr Nephrol 2012; 27: 941-948Santos Jr ACS, Lima EM, Penido MGMG et al. Plasma and urinary levels of cytokines in patients eith idiopathic hypercalciuria. Pediatr Nephrol 2012; 27: 941-948Картамышева НН, Сергеева ТВ, Кучеренко АГ и др. Моноцитарный хемоаттрактивный протеин-1 (MCP-1) в патогенезе изменений тубулоинтерстициальной ткани у детей с хроническим гломерулонефритом. Нефрология и диализ 2005; 7 (4): 443-444Картамышева НН, Сергеева ТВ, Кучеренко АГ и др. Моноцитарный хемоаттрактивный протеин-1 (MCP-1) в патогенезе изменений тубулоинтерстициальной ткани у детей с хроническим гломерулонефритом. Нефрология и диализ 2005; 7 (4): 443-444

The authors declare that there are no conflicts of interest present.